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RÉSUMÉ
Il y a une obligation générale d’obtenir le consentement d’un patient avant de
pouvoir l’inscrire à un projet de recherche scientifique ou avant de communiquer
de l’information personnelle relative à sa santé. Les motivations à donner un
consentement dépendent à la fois du patient et du professionnel de la santé
impliqués dans le processus.
Les caractéristiques de médecins et de patients ayant et n’ayant pas donné leur
consentement à participer à un projet de recherche impliquant l’utilisation d’un
dossier médical électronique pour gérer des prescriptions ont été analysées.
Les caractéristiques qui augmentent le taux de consentement comprennent le fait
que le patient soit plus âgé, soit de sexe féminin et effectue plus de visites à la
clinique médicale. Par contre, un nombre plus élevé de visites auprès de services
d’urgence et un nombre plus élevé de visites à des pharmacies distinctes sont
directement relié à un taux de consentement moins élevé.
Mots clés: système informatisé d’aide à la décision, prescription de médicament,
dossier médical électronique, diffusion des innovations, consentement éclairé.
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ABSTRACT
There is a general obligation to get a patient’s consent to participate in a scientific
research study or to communicate personal health information. Motives for giving
consent may depend on both the patient and the health professional involved in
the consent process.
Characteristics of physicians and of patients consenting and non-consenting to
participate in an electronic medical record for prescription management research
project were analyzed.
Characteristics that increased the chance of consenting included patients’ older
age, being female and more visits to the general practitioner. However, a higher
number of visits to emergency rooms was directly correlated with a lower consent
rate, as was an increased number a visited pharmacies.
Keywords: Computer-aided decision support, Prescription medication, Electronic
medical record, Diffusion of innovation, Informed consent.
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1CHAPTER 1- INTRODUCTION
Background
Drug prescription management is the focus of extensive research regarding the
suboptimal use of dmgs and exploding costs. In order to address these issues, health
care professionals are looking into ways to increase drug prescription performance.
The introduction of computer technologies to manage dmg prescriptions is seen as a
favored way to increase the general drug prescription performance.
Medical drug consumption is growing in Canada due to various factors including a
growing and aging population and the marketing of new promising drugs. In itself,
prescription drug use represents the fastest-growing sector of health care spending.
Recent figures estimate that, in 1999, total spending on prescribed drugs in Canada
was of $10.3 billion, followed by a further increase to $11.4 billion in 2000 (10.3%
and 10.6% annual increases) (Canadian Institute for Health Information, 2001).
Regarding the suboptimal utilization of prescription drugs, the related negative
consequences include increases in the risk of adverse drug effects and negative
effects on clinical benefits and cost-efficiencies. This suboptimal utilization lias
many negative implications and is very important as adverse drug effects are the 6th
cause ofmortality in the United-$tates (Lazarou & al, 1998; Hallas & al, 1990) and
account for 2%-10% ofhospital admissions (Colt & Shapiro, 1989; Ives & al, 1987;
2Jha & ai, 2001; Chan & ai, 2001; Cooper, 1999; Raschetti & ai, 1999; Stanton & ai,
1994). Moreover, aimost haif of adverse drug effects, inciuding dosing and
administration errors, over and under-compiiance, inadequate foiiow-up, and drug
disease, drug-aiiergy and drug-drug interactions, are preventabie (Bates, Boyie &
ai, 1995; Bates, Cuiien & ai, 1995; Lesar, 2002; Haikin & ai, 2001).
Incompiete information on current medication at the time of prescribing, errors in
dose and drug seiection, transcribing errors and unnecessarily costiy prescribing are
eiements that contribute to suboptimai utilization of prescription drugs that could be
addressed by information teclmoiogy (Arrnstrong & Chrischiiies, 2000; Bates & ai,
2001; Noian & ai, 1999; Papshev & Peterson, 2001, Noffsinger & Chin, 2000;
Rivkin, 1997; Monane & ai, 1998). There is an obvious risk of having incompiete
information as over 40% of elderly patients will use more than one pharmacy, 70%
wiii have more than one physician prescribing medication, and as many as 5% wiii
have more than six (Tamblyn & ai, 1996). Furthermore, over one-third of eideriy
peopie wiii be prescribed a drug contraindicated by age, current disease, aiiergy, or
another drug (Monane & ai, 1998; Ostrum & ai, 1995). Aiso, transcription errors
are made in 10%-15% of prescriptions, of which 2% are serious, and increase with
voiume, poor writing, and ievei ofpharmacist training (Bates, Cuiien & ai, 1995).
High costs reiated to medicai drugs are aiso an incentive to promote a better
management of drug prescription. Drug prescribing must aiso be better managed in
order to be abie to address the general rise in heaith care costs, and of drugs use in
3particular. Health care data indicates that, for over 31 million existing Canadians,
health expenditures, which includes spending by federal, provincial and local
governments, workers compensation boards and the private sector, was of 95.1
billion of dollars in year 2000. This corresponds to 9.3% of gross domestic product.
0f that amount, 30.2 billion was hospital costs, 12.8 billion for physicians, 11.2
billion to other professionals and 14.7 billion to prescription and non-prescription
drugs. Global Canadian health expenditure climbed from 75.3 billion in 1996 to
95.1 billion in 2000, while the percentage this represents relative to the gross
domestic product went from 9% to 9.3% (Canadian Institute for Health Information,
2000). On an individual basis, Canadians spent, in 2001, 4.7% of all personal
expenditure on medical care and health services (Statistics Canada, 2003).
According to the August 2000 report Understanding Canada Health Care Costs
by Canada’s Provincial and Territorial Ministers of Health, the overali provincial
and territorial operating health expenditures have gone up substantially over the
past two decades, from about $11 billion in 1977/78 to almost $56 billion in
1999/2000. The report states that the cost increase is likely an underestimate, as it
does flot take into account cost accelerators such as emerging and new technologies,
the increased incidence of chronic and new diseases, and the cost of renewal. This
could bring the total of provincial and territorial health spending to over $100
billion within the next decade. Only for poor compliance results, it is estimated that
the costs are of $3.5 billion per year in health care expenditures and that it
represents 5.3% of hospital admissions (Sullivan & al, 1990). A review of the
literature evaluating the direct costs of prescription drug related problems in Canada
4reveal that hospitalization costs and ioss ofproductivity account for as much as 7 to
9 billion dollars (Coambs & ai, 1995).
The development of electronic medicai records, or e-records, aims at resolving the
problems of incomplete information on current medication at the time of
prescribing, errors in dose and drug selection and transcribing errors and
unnecessarily costly prescribing. Jncreasingly, the paper-based medical chart is
being replaced by a computerized chart. Advantages of an e-record over a
conventionai paper record inciude the readily availability of patient information as
they contact and re-contact players in the health care system, the permanent status
of the patient’s medicai history and the fact that the patient does not need to be
asked the purpose of his visit, in a different way, at every encounter. furthermore,
medical conditions that pose a serious heaith risk can be flagged by an adequate
sofiware algorithm in order to avoid medical errors. To date, there is evidence that
computerized systems are effective in hospitais for reducing preventable adverse
drug-related events (Bates & ai, 199$; Hunt & al, 1998; Raschke & al, 1998, Bates,
2000), improving cost-effective decision-making in selection of drug therapy
(Pestotnik & al, 1996; Hershey & al, 1986; Gehlbach & ai, 1984; Rossy & Every,
1997; Evans & al, 1998) and possibly improving clinical decision-making for
individuai drug-dose calculation (Poiier & al, 1993; Casner & al, 1993; Mungall &
ai, 1994; Walton, 1999; Fitzmaurice, 1998). furthermore, an integrated physician
pharmacy-patient drug management system has the potentiai to: 1) reduce
prescribing errors, 2) reduce transcription errors, 3) reduce utilization errors related
5to the failure to communicate prescription stop and change orders, and 4) provide
compliance monitoring tools.
Because of the complexity of the health system as a whole, and of drug prescription
management in particular, and because of the high costs related to the
implementation of necessary new technologies and managerial procedures, it is
necessary to judicially evaluate ways to improve the system. Research can help
evaluate new drug management paradigms through their implementation on a small
scale, as pilot-projects. Such a project, the Medical Office for the Twenty First
Century (MOXXI), was carried out in Montreal. The second phase of the Medical
Office for the Twenty First Century initiative was carried out in Quebec in 1999-
2000 to study how e-records could be used to manage information about
prescription drugs. More precisely, the MOXXT-II project aimed at testing the
potential benefits of electronic transmission of current drug profiles of patients,
which would benefit both the patient, who would receive better services, and the
physician, whose practice would be enhanced. The MOXXI-ll project aimed at
enhancing the quality of clinical care delivered by physicians by improving access
to clinical data, including information about drugs prescribed by other physicians
and laboratory results, and implementing a computer-generated patient alert system
that would red-flag incompatible drug prescriptions. These goals are in line with the
maximization of drug prescription and the will to curtail adverse drug affects
caused by errors in prescriptions.
6A crucial aspect of the MOXXI-II proj ect was, as with many procedures involving
patients, that patients were required to give consent to certain procedures. In this
case, consent was required to authorize their physician to obtain their drug
information ftom the Régie de 1 ‘assurance-maladie du Québec (RÀMQ), the public
govemment managed health insurance institution. This consent requirement had a
double implication. Not only were the patients asked to give consent to the
communication of personal health information, they were asked to do so in the
context of a research project where a new technological means of intervention was
tested. Asking for consent in such a research scenario raises issues of privacy and
confidentiality of health information, which is oflen regarded as highly sensitive
(Canadian Institute of Health Research, 2002), especially that there is health data
linkages with different health professionals. Patients, health professionals and
health care providers have expressed the need for controls on the collection, use and
disclosure ofpersonal health information.
At present times, general consent requirements regarding personal health
information, including the use of secondary data for epidemiological and population
health research, are not clearly defined in practice. Nevertheless, because consent to
communicate personal medical information is, and will be, a requirement for certain
aspects of medical practice and research and that refusal to give consent may be
detrimental to clinical practice and medical research, it is necessary to understand
the parameters of required consent. To further the understanding of consent
scenarios, this thesis will see to establish characteristics of patients and physicians
7as predictors of consent to the communication of personal health information in the
context of the implementation of a new technology. Knowing what variables are
related to a low and high consent rate will help health care professionals and
researchers in their work by providing a clearer understanding of bias and consent
approval.
it is important to understand the context within which patient consent is required to
fully appreciate the scope and implications of this research. In order to accomplish
this goal, a literature review of the theoretical foundations of consent requirements
and health technology innovation will follow the description of the research’s
objectives.
The literature review will be followed by a presentations of the methodology of the
study, followed by an exposé of the resuits, respectively through univariate and
multivariate data analysis and a discussion of said results. A final chapter will
summarize and conclude the research.
$Objectives
The objective of the study is to identify patient and physician characteristics
associated to their willingness to participate in studies where there is
communication of their personal health information.
Sociodemographic and health related characteristics of patients will be analyzed in
conjunction with sociodemographic and professional practice-related characteristics
of physicians to establish if some characteristics, individually or in association with
others, can help predict patient consent rate to participate in an electronic medical
record study.
This study aims at bringing a valuable contribution to the study of patient consent to
the communication of personal health information through the analysis of consent
rate and physician bias.
9CHAPTER 2- LITERATURE REVIEW
The ethical and legal notions related to the concept of consent in health care will be
the subjects of the first section. The second section will define what constitutes an
electronic medical record, what advantages it can bring to the health care sector and
what are the attitudes of health professionals who had to use one. This will be
followed by a literature overview of patients’ and health professionals’ attitudes
towards the mandatory consent. Finally, the conceptual framework of the research
will be elaborated using the different variables recovered from the literature
exploration.
Ethics, Law and Consent in Health Care
The sensitive nature of personal health data requires that the implementation and
the use of an EMR take into account notions of privacy and confidentiality of health
information, in both clinical and research environments. These notions of privacy
and confidentiality are at the source of the patient consent requirement to
communicate personal health data.
10
The following section will elaborate on the foundations of patient consent through
an exposé of ethical principles and legal requirements. The practical aspects of
patients’ consent to participate in research will also be explored. Ethical and legal
issues must be explored because they are the foundations of the notion of consent.
Therefore, an understanding of what constitutes ethical and legal issues is necessary
to establish the different characteristics associated with patient consent rate.
Consent is seen, for the benefit of this research, as a dependent variable: it is given
or it is not given.
Ethical issues
Medical ethicists point to two ethical rationales when discussing the necessity of
protecting personal health information. The justification most commonly offered is
a consequentialist, or utilitarian, one. The other justification relates to a
deontological approach (Appelbaum, 2002).
The consequentialist, or utilitarian, approach supposes that patients must have the
utmost confidence in the fact that their physician is going to keep any information
they give them confidential in order for the diagnosis to be adequate and the
treatment to be effective. Patients must trust the fact that their physician will not
disclose personal information to third parties (Gillon, 1985). This trust is important
so that the patient will flot withhold information to their physicians or avoid going
11
for treatment. A Gallup survey conducted in 2000 for the American Institute for
Health Freedom found that 78% of respondents felt that the confidentiality of their
health information was very important (The Gallup Organization, 2000). In Canada,
a 1999 survey conducted by the Angus Reid Group on behaif of the Canadian
Medical Association showed that 65% of Canadians had concems over privacy and
confidentiality of personal information relating to health information such as the
information about their physical and mental history and status contained in medical
records. When analyzing if individuals acted in a particular way to protect their
medical privacy, a study revealed that 15% of a national sample in Califomia went
out of their way to do so, including not seeking care or giving inaccurate or
incomplete information (Califomia Health Foundation, 1999). Furthermore, other
research reveals that 25% of studied adolescents would abstain from care if they
thought their parents would find out about their health inquiries (Cheng & al.,
1993).
A second ethical argument, the deontological approach, has also been developed by
advocates of medical privacy who felt that there was a dearth of data supporting
consequentialist justifications. Proponents of the deontological approach argue that
privacy is a good concept in itself and does not have to be viewed in relation to the
positive consequences it can have on a patient’s health (Shuman & al., 1986;
Jmwinkelried, 199$). The daim is that individual autonomy should be encouraged
in society, and that privacy helps the advancement of this autonomy.
12
Professionals of the health care sector have incorporated ethical guidelines
regarding privacy, confidentiality and related consent into their medical practice.
The medicai profession had adopted as a principle the notion that physicians have
the duty to respect the patient’s privacy and confidentiality unless they are relieved
from this obligation by their patients offering consent to the disclosure of their
medical information.
In Canada, the Canadian Medical Association (CMA) tackies the issue of ethics in
two documents: The CMA Code of Ethics and the CMA Health Information
Privacy Code. The Code of Ethics latest version dates from 1996 and is based on
the fundamental ethical principles of medicine that are compassion, beneficence,
non-maleficence, respect for persons and justice. The CMA code had a section on
Confidentiality where section 22 states that a physician shouid “respect the patient’s
right to confidentiality except when this right conflicts with your responsibility to
the law, or when the maintenance of confidentiaiity would result in a significant
risk of substantiai harm to others or to the patient if the patient is incompetent; in
such cases, take ail reasonable steps to inform the patient that confidentiality will be
breached.” Subsequent sections relate to confidentiality when a third party is
involved and the provision of a medical record copy upon request. As for the CMA
Health Information Privacy Code approved in 199$, it includes principles to deal
with issues of protecting the privacy of patients, the confidentiality and security of
their health information and the trust and integrity of the therapeutic relationship. It
is based on the Canadian Standards Association’s Model Code for the Protection of
13
Personal Information (CSA Code), of 1996, and describes the minimum
requirements to protect the privacy of patients and the confidentiality and security
of their health information. This code gives examples of what constitutes patients’
fundamental rights and of basic duties meant to ensure that the privacy rights are
adequately respected and protected. About consent, the CMA Health Information
Privacy Code states that, except for very limited conditions conceming
nonconsensual collection, use, disclosure or access permitted or required by
legislation or regulation that meet the requirements of the Code, or ordered or
decided by a court of law, consent is required for health information collection, use,
disclosure or access for any purpose. It also states, at section 5.9 under the Consent
Principle subdivision, that “Patient consent for secondary nonlegislated purposes
shah be express, voluntary and fully informed.” The code also gives provisions
relating to individual access, security, accountability, transparency and openness,
and collection, use, disclosure and access to health data.
As for the Code of Ethics specific for Quebec physicians, it has been written and
approved by the Collège des médecins du Québec. This Code of Ethics of
Physicians, which came into effect November 7th 2002 and has legal force, is
viewed as being more stringent than the CMA code (Benady, 2002), including the
obligation to use health-care resources wisely (section 11), to not go on strike
(section 12), to own up to mistakes (section 54) and to ensure patient’s right to
accuracy of information (section 88). About privacy and confidentiality, the Code
enacts at section 20, amongst other provisions, that “A physician, in order to
14
maintain professional secrecy, b must keep confidential the information obtained
in the practice ofhis profession; (...) 3o must take reasonable means with respect to
the persons with whorn he works to maintain professional secrecy; (and) 5o may flot
divulge facts or confidences which have corne to his personal attention, except
when the patient or the law authorizes him to do so, or when there are compelling
and just grounds related to the health or safety of the patient or of others;”.
Furthermore, section 21 lists items that must be listed in the patient’s record by a
physician who communicates information protected by professional secrecy,
inciuding “2o the identity of the person exposed to danger or of the group of
persons exposed to danger; (...) 3o the identity of the person to whom the
communication was made, specifying, according to the case, whether it was the
person or persons exposed to danger, their representative or the persons likely to
corne to their assistance; (and) 5o the danger he had identified;”. With respect to
research and consent, a physician must ensure “that a voluntary and informed
written consent, which is revocable at ail times, is obtained from each subject
before he begins his participation in the research project or when there is any
significant change in the research protocol” (section 30.2). Furthermore, a
“physician must, before undertaking his research on humans, obtain approval of the
project by a research ethics committee that respects existing standards, notably in its
composition and procedures” section 31).
Another important code of ethics for research in the medical field in Canada is the
Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans,
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where the three councils are the Natural Sciences and Engineering Research
Council of Canada, the Social Sciences and Humanities Research Council of
Canada and the Canadian Institute of Health Research. The practical aspects of this
policy statement will be discussed further on as it has direct practical implications
for research.
In the case where a physician would deliver a drug prescription to a patient and
where this prescription would be sent electronically to a pharmacist, because of this
phanTlacists’ implication, a section on confidentiality of the Quebec Code of Ethics
ofpharmacists would also have to be followed. It states, at article 3.06.01, that “A
pharmacist must respect the secrecy of alI confidential information acquired in the
practice of his profession” and that “a pharmacist may be released from
professional secrecy only upon the authorization of his patient or when so ordered
by law.”
Legal issues
In the province of Quebec, privacy concerns in health care must obey precise laws
and regulations.
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The concepts of privacy, confidentiality and security are distinct concepts that are
nevertheless related. This is particularly the case when consent to electronic
exchange of information is at the core of a system.
Privacy and confidentiality must not be confused. A person’s name and address, for
example, are elements relating to privacy but are not necessarily confidential.
Otherwise, a document may be confidential without having any privacy inference,
like a government memo. As for the concept of security, it relates to safety
measures that concem the integrity of data and information exchange. Privacy and
confidentiality concepts are essential to define because they are the comerstone
concepts of consent. In other words, you need to understand the notions of privacy
and confidentiality in order to adequately comply with consent requirements.
Various laws and regulations regarding issues of privacy, confidentiality, security
and consent must be taken into account in the province of Quebec context.
The Quebec Charter ojhuman rights andfteedoms states that, in article 5:
“Every person lias a right to respect for lis private life.”
The Civil Code ofQuebec states at article 35 that:
“Every person has a right to the respect ofhis reputation and privacy.”
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“No one may invade the privacy of a person without the consent of the person or
his heirs unless authorized by law.”
Article 19 of the Act respecting health services and social services gives the basic
requirements regarding consent:
“The record of a user is confidential and no person may have access to it except
with the consent of the user or the person qualified to give consent on his behaif,
on the order of a court or a coroner in the exercise of his functions, or where this
Act provides that an institution may be required to release information contained
in the record.”
Two other important Quebec laws have to be taken into account when dealing with
aspects of privacy and confidentiality. The first of these laws is the Act respecting
Access to documents held by public bodies and the Protection of personal
information enacted on lune 22, 1982, thereby creating the Commission d’accès à
l’information du Québec (Access to Information Commission). The second ofthese
laws is the Act to establish a legatframeworkfor information technology enacted
June 21, 2001, which establishes a legal framework for the exchange of electronic
documents. This last law also gives requirements relating to the security of
technologic documents.
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In Quebec, the Commission d’accès à l’information (CAl) plays an important role
regarding privacy and confidentiality issues and questions of consent in the health
care sector in the province of Quebec. The CAl is responsible for administering the
Act respecting access to documents held by public bodies and the protection of
personal information. The Act applies to government departments and agencies,
municipalities and agencies under municipal control, educational institutions and
heaÏth and social service network institutions. The CAl is also responsible for the
application of the Act respecting the protection of personal information in the
private sector. All enterprises supplying goods and services must comply with this
Act if they collect, store, use or communicate personal information. The CM holds
the role of an administrative tribunal (The Adjudication Function), it is responsible
for overseeing compliance with the obligations imposed upon public bodies and
private sector enterprises conceming the collection, storage, use and communication
of personal information (The Supervisory and Control Function) and it facilitates
the implementation of concrete measures designed to ensure compliance with both
the spirit and the letter of the law (The Advisory Function) (Commission d’accès à
l’information, Mandates and Functions).
Throughout its decisions and publication, the CAl has established that a given
consent must be obvious, free, enÏightened, and given for a specific reason and a
specific length oftime.
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Given its essentiai and inevitable role regarding privacy and confidentiality issues
in the province of Quebec, the CAl ofien intervenes in matters regarding health and
information. Moreover, the CAl is oflen requested when carrying out research
projects invoiving personal health data.
The commission seems to acknowledge the evolutionary nature of health care
management, particularly regarding new technologies. It has recently studied
matters relating to electronic exchange of data in the health care system. On this
subj ect, the CAl recently recognized that “The networking of electronic clinical
records challenges the mies goveming the transfer of health information. The
Commission, therefore, reiterates the importance of reviewing the Québec legal
framework for access to and the protection of health data in light of the new
dynamic for the exchange of clinical information, in the interest of the patient”
(Commission d’accès à l’information. Étude sur l’inforoute de la santé au Québec:
enjeux techniques, éthiques et légaux, p. 3, 2001; Commission d’accès à
l’information, $tudy of the Health Information Highway in Québec: Technical,
Ethical and Legai Issues, p. 3, 2001).
At the Canadian federai level, the Personal Information Protection and Electronic
Documents Act (PIPEDA) sets out the ground mies for how organizations may
coiiect, use or disclose personai information in the course of commercial activities.
Although the PIPED Act was originaiiy intended to regulate commercial use of
electronic information, it is 110W the legai standard that wiii be used for heaith
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researchers when they access personal information. However, personal information
may be used for “research purposes” without knowledge or consent under certain
circumstances “for purposes that a reasonable person would consider appropriate in
the circumstances” (section 3). At present, Quebec is the only province with a
personal data protection law in effect that applies to the provincially regulated
private sector. In his Report to Parliament Concerning Substantially Similar
Provincial Legislation (May 2002), on page 15, the Privacy Commissioner of
Canada concluded that “Based on the foregoing analysis, I believe that Quebec’s
Act Respecting the Protection of Personal Information in the Private Sector
legislation is substantially similar to the PIPED Act in ternis of the extent to which
it protects personal information.”
Practical aspects
In the context of a scientific research project on the use of electronic medical
records in a medical setting, these legal requirements and ethical guidelines are
established in policies enacted by hospital Research Ethics Boards (REBs) or, if
done in a university research setting, by an Institutional Review Boards (1kB s).
In the specific context of the MOXXI-II project, the research project had to obtain
McGill University’s IRB approval before undertaking their research.
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McGill University follows the Tri-Council Policy Statement: Ethical Conduct for
Research Involving Humans, where the three councils are the Natural Sciences and
Engineering Research Council of Canada, the Social Sciences and Humanities
Research Council of Canada and the Canadian Institute of Health Research, and its
1RB declares that its working procedures are consistent with the published
guidelines of the Canadian Institute of Health Research. Furthermore, as a
registered University IRE, the McGill IRB works in accordance with the published
regulations of the US Department of Health and Human Services, and holds a
Multiple Project Assurance Agreement approved by the Office for Human Research
Protections (OHRP) that includes an Inter-Jnstitutional Agreement between the
University and its affihiated hospitals. Deliberations ofthe Committee must conform
to applicable laws, including, where relevant, the Quebec Civil Code and the
Quebec Act respecting health services and social services. The Minister of Health
and Social Services has designated the McGill 1kB to carry out the review,
approval and follow-up for research to be conducted with chiidren and cognitively
impaired individuals as referred to in Article 21 ofthe Civil Code ofthe Province of
Quebec (McGill University, IRB Mandate and Working Procedures).
Furthermore, because of the academic nature of the MOXXI project, it is also
necessary for researchers to consult research ethic guidelines that concem these
subjects, such as the ones given by the McGill University Ethical and Legal Aspects
ofResearch involving Human Subjects conducted in the faculty ofMedicine and
Affihiated Hospitaïs first written in 1993 and having been revised in 1994 and 1999.
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Adopting the Electronic Medical Record
Like in every work sector of modem society, the health care sector is increasingly
using information technologies to improve outcomes. This section will describe the
various potential uses of information technologies in health care and how
professionals and patients respond to these new technologies, then will be exposed a
general theory describing characteristics ofearly adopters of technologies.
An important benefit of the use of information technologies in health care is that
they enable linkages between clinical data and administrative data to improve
quality of care and reduce the need to collect and re-collect the same information
(Gostin & Hadley, 1998; Fitzmaurice & al., 2002). Other benefits brought by
information technologies include the increasing use of email for correspondence
between patients and physicians (Kane & Sands, 1998), the use of accessible
internet and specialized web sites like PUBMED by the public and health
professionals who can quickly find a wealth of information on health, including
articles and research about medical conditions and treatments (Hayes & Lehmann,
1996) and the ability to act from a distance through the means of telemedicine
(Lehoux & al., 1999; Mitka, 1998).
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Automated technologies will most likely enable patients’ electronic medical records
to be recorded longitudinally from birth to death and be accessed through national
health care information infrastructures (Gostin, 1997) whule many benefits have
been identified in relation to the systematic collection and use of electronic health
data. More accurate data improves clinical care through faster and more accurate
diagnoses (Hunt & al., 1998), increased checks on medical procedures (Bates & aï.,
1998) and prevention of adverse dmg reactions (Raschke & al., 1998). Also,
medical research and public health studies of morbidity and mortality across
populations are facilitated by the increased access to information (Gostin & al.,
1996; flahault & al., 1998). On the technical side, new computer hardware and
software facilitate network security and information protection through the
requirement of personal codes for access to information, layers of access to
information, firewalls and encryption programs, amongst others.
However, the use of information technologies in the health care sector lias brought
significant challenges to the sector. A major challenge concems the issues of patient
privacy and confidentiatity of personal health information. These are important
issues because individual health data is considered to be among the most sensitive
type of personal information (Gostin, 1997). Privacy in a medical setting is defined
as being information regarding a person’s medical condition for which that person
has interest in maintaining the control. Protecting personal health data is critical to
the good workings of the medical profession because it enables trust in the patient
physician relationship. Not keeping personal health data in a secure fashion can lead
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to unauthorized use and disclosure of this data (Beauchamp & Chuldress, 1994),
which can lead to possible embarrassment and discrimination (Gostin & Hodge,
1998). The computerization of medical information into databases makes
information more accessible and also easier to change, be copied, disclosed or
deleted by more people than conventional paper records (National Research
Council, 1998).
A particular field that is greatly transformed by computer technology is the one of
patient medical record management. A literature review shows that there are
different terminologies used to identify a patient record stored in electronic format,
including Electronic patient record, Electronic medical record and Electronic
medical record. The later will be used for this study. Furthermore, of the different
definitions proposed by various health care organizations, the most thorough
definition seems the one given by the Institute ofMedicine (Dick & al., 1997) ofthe
United states in 1997: “A computer-based patient record is an electronic patient
record that resides in a system specificaÏly designed to support users by providing
accessibility to complete and accurate data, alerts, reminders, clinical decision
support systems, links to medical knowledge and other aids” (p. 55).
Patient medical records are increasingly digitalized and stored in govemmental and
other institutional electronic databases. Electronic medical records offer many
potential advantages over paper-based records, including allowing providers to
access information from a variety of locations and to share information more easily
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with other potential users, allowing multiple users to have simuÏtaneously access to
information, allowing control of data access with logs to keep a history, and the
possibility to present the information in different ways tailored to different clinical
needs (Dick & al., 1997).
Characteristics of innovation adopters
Furthermore, it is essential to have a basic understanding of the theory of diffusion
of innovations to fully appreciate the importance of identifying adopter
characteristics when implementing a new technology or mode of intervention.
Adopter characteristics can serve as a base to appreciate the characteristics of
physicians adopting a new technology and mode of intervention like an EMR.
Following is a brief overview of the general diffusion of innovations theory by
Everett M. Rogers (1995), with an emphasis on iimovativeness and characteristics
of earlier adopters of innovations.
Everett M. Rogers defines an innovation as being “an idea, practice, or object that is
perceived as new by an individual or other unit of adoption” (Rogers, 1995, p. 11).
Example of “other” units of adoption would be, in the health care sector, a hospital,
a group ofprofessionals, a regional health board or patients.
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Rogers (1995) has been studying for decades how individuals and systems adopt
innovations and has published, in 1995, the fourth edition of a compendium on the
subject titled “Diffusion of innovations” that is widely considered as the classic text
in the field as the author has done a great effort to synthesize ail the most valid
findings and research on the subject. The origin of diffusion research dates,
according to Rogers (1995), to a 1943 study by Ryan and Gross, two researchers
from at Iowa State University in the field of rural sociology, who used interviews
with adopters of an innovation to establish characteristics related to the adoption
process.
In his book, the author elaborates a classification of adopters as he studies the
adoption rate of innovations through time. Study data establishes that the rate of
adoption of an innovation follows a normal bell-shaped curve showing the
frequency, or number, of adopter through time. The rate of adoption can also be
displayed as an S-shaped curve showing the cumulative rate of adoption through
time. Theory establishes at between 10 and 20 percent the number of adopters
needed so that an innovation will be viable and further individuals or systems adopt
it. It is predicted that if an innovation cannot reach this acceptance zone, its
diffusion will most likely fail.
Adopters are classified into categories of innovativeness, from individuals who are
predisposed to being mnnovative and who will adopt an innovation early than to
individuals who prefer the status quo or are very traditional and who will accept last
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an innovation. The different adopters are categorized as innovators, early adopters,
early majority, late majority and laggards.
Y LATE
2.5 IDOPTERS MAJORfl’Y MAJORTTY 16
13.59 34 349
Figure 1. BeIl shape curve showing the distTibution of
different categories of adopters with percentages.
The first group, innovators, represents the first 2.5% of adopters of an innovation.
Rogers defines them as being venturesome to an almost obsessive point. They have
a desire for the rash, the daring and the risky. Their interest in new ideas has them
communicating more with like-minded individuals than with their peers and be
disrespected by other members of a local system. The tendency to accept new
innovations is oflen backed by their complex technical knowledge and financial
resources. While being essential members of the community because they bring
new ideas into their system, they must be prepared to accept set-backs when new
ideas prove unsuccessful, as some inevitably do.
The next group representing 13.5% of adopters is composed of early adopters, who
are more integrated to their local system than are innovators. They are respected by
their peers and are viewed as role models by many other members of their social
system regarding the adoption of innovations as they decrease uncertainty about a
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new idea by adopting it. Early adopters are oflen sought by change agents as
individuals who will embrace an innovation and speed its diffusion process. They
must, in order to continue to eam the esteem of localites, make judicious innovation
decisions.
Then cornes the early rnajority, which represents 34% of adopters, bringing the total
of adopters to 50% and the top of the bell curve. The early majority adopts an
innovation before the average number in a system. They are individuals who much
interact with their peers while seldom being opinion leaders in their system. The
early majority, which makes up one-third of the members of a system, is an
essential bridge between early adopters and the late majority as they secure the
adoption of an innovation through the system’s interpersonal networks. They have
an intentional willingness to adopt an innovation, but are not going to lead this
adoption.
The following group, the late majority, also is comprised of 34% of adopters, or
one-third of the total. They adopt an innovation afier the member of a system, either
because of an economic necessity or because of pressure from peers. The late
majority is skeptical and cautious of innovation and will only adopt one afier most
other mernbers of their system have done so. The weight of systern norms and the
disappearance of uncertainties about a new idea are elements that prompt the late
majority to adopt an innovation.
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The final group is cornposed of laggards, which represent the last 16% of adopters
and are considered to be almost isolated in their social system. They are viewed as
traditional individuals having the past as a reference point and who mainly interact
one with the other. Their suspicion of innovations and change agents makes them
resistant to new ideas. This resistance is due in part to the fact that their resources
are limited and they must be certain that a new idea will not fail before they adopt
it.
This theoretical classification is based on empirical research and has a standardized
percentage of respondents in each category. The frequency distribution is
asymmetrical in that there are three adopter categories to the lefi of the mean and
two to the right. This is explained by the fact that innovators and early adopters
form clear and distinctive groups, which cannot be combined, and that laggards
form a quite homogenous group and therefore cannot be devised in two categories.
It must be understood that these five adopter categories represent ideal types, which
are not just an average of all observations about a category established to make
comparisons possible, but are abstractions made from empirical investigations.
Exceptions to the ideal types can 5e found in every category.
Furthermore, this classification is not exhaustive for it does not take into account
incomplete adoption or non-adoption, as the author advances in lis chapter defining
The Method of Adopter Categorization, at page 263. Rogers states that this problem
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is eliminated when a series of innovations are combined into a composite
innovativeness scale.
The authors refers to a voluminous literature research about variables related to
innovativeness and summarizes this diffusion research in a series of generalizations
under three banners that are socioeconomic status, personality values and
communication behavior. Earlier adopters are compared to later adopters.
The first observation on socioeconomic characteristics of adopters is that earlier
adopters are not different from later adopters in age. Rogers (1995, pp. 269-272)
found inconsistent evidence about the age relationship when studying 228
researches on the subject, with about haif showing no relationship and a few
concluding that early adopters are younger, and stili a few stating the opposite.
Other observations state that earlier adopters have more years of formal education
than late adopters and that they are more likely to be literate, have higher social
status than later adopters, status depending on such variables as income, level of
living, possession of wealth and occupational prestige. Another observation
describes earlier adopters as having a greater degree of upward social mobility than
later adopters, maybe even using the adoption of innovations as means of climbing
to higher levels of social status. A last observation on socioeconomic characteristics
of adopters describes the earlier adopters as having larger social units (farms,
schools, companies and so on) than later adopters.
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Personality variables have flot received as much consideration in research, in part
due to difficuities of measuring personality dimensions in field interviews (Rogers,
1995, pp. 272-273). The first generalization about personality variables establishes
that earlier adopters have greater empathy than later adopters, with empathy being
the ability to project oneseif into the role of another person. This enables the
innovator to think counterfactually and better communicate with individuals who
are in other systems. Another observation states that earlier adopters may be less
dogmatic than later adopters, thus having their belief system more open to new
ideas. However, evidence is flot strong to support this generalization. Other
observation makes the author state that early adopters have a greater ability to deal
with abstraction, a greater rationality, a greater intelligence, a more favorable
attitude toward change, are better able to cope with uncertainty and risk, a more
favorable attitude toward science and are less fatalistic than later adopters, fatality
being the perceived impression of not being in control of a situation. Finally, earlier
adopters have higher aspirations (for formai education, occupations, and so on) than
later adopters.
The first communication behavior generalization states that earlier adopters have
more social participation than later adopters (Rogers, 1995, pp. 273-274). Others
generalization state that earlier adopters are more highly interconnected through
interpersonal networks in their social system and that they are more cosmopolite
than later adopters in the sense that innovators’ interpersonal networks are more
likely to be outside of their system than inside. Others, stili, state that earlier
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adopters have more change agent contact, a greater exposure to mass media
communications channels, greater exposure to interpersonal communication
channels, seek information about innovations more actively and have greater
knowledge of innovations than later adopters. Finally, earlier adopters have a higher
degree of opinion leadership than later adopters.
Rogers’ theory of diffusion of innovations has been used to study the diffusion of
innovations in various fields. The author himself uses his work, with colleagues, to
study subjects as the diffusion of patient oriented activities in Dutch community
pharmacy (Pronk & al., 2002) and the adoption ofwork-sit AIDS programs (Backer
& Rogers, 199$). He also applied his theory to the diffusion of the concept of
Beyond War, a nonpartisan educational movement originating in the United States.
The tenants of this concept are that war is obsolete, as is nationalism, and that the
world is one interconnected, interdependent global system. Collaborating a chapter
to the book Breakthrough: Emerging New Thinking, Soviet and Western Scholars
Issue a Challenge to Build a World Beyond War, Rogers elaborates the framework
for the Beyond War idea to be diffused throughout society.
The classic theory of diffusion of innovations had been used to study, amongst
other subjects, the adoption of mobile internet services (Pederson, 2001), language
and learning (Vanderslice, 2000), electronic commerce adoption by small and
medium-sized enterprises (Kendall & al., 2001), management of new software
engineering tools (Mathiassen & Sørensen, 1997), introduction of new ideas into
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organizations (Manns & Rising, 2003) and solar oven use in Lesotho (Grundy &
Grundy, 1994).
In the health care sector, Rogers’s theory of innovations has been used to study the
diffusion of innovations into psychiatrie practice (Freedman, 2002), physician order
entry in hospitals (Ash & al., 2001), the adoption of a Picture Archiving and
Communication System (PACS) in a Quebec hospital (Trudel & Paré, 2002) and
the relation between clinical team characteristics and the adoption of an online
evidence information system (Goslin & ai, 2003), as well as a general study, with
recommendations, regarding the dissemination of innovations in health care
(Berwick, 2003). A study describing the characteristics of woman who were early
adopters of elinical BRCA1/2 testing is one of the oniy possible few studies that
considers the patient’s side in a seenario of new health technology adoption
(Armstrong & ai, 2003).
A more thorough analysis of the aeceptance of electronic medical records would
have to take into account other factors than adopter characteristics and eould
include different theoretical models such as the Knowledge Barriers Theory
(Atteweli, 1992; Tanriverdi & lacono, 1999) and the Teehnology Aeceptance
Model (TAM) initially developed by Davis F.D in 1989.
Innovation characteristics and adoption context
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Innovation characteristics and adoption context are interrelated as the behavior of
the adopter is influenced at the same time by the innovation’s characteristics and by
the context within which the innovation is adopted.
The perceived characteristics of an innovation are going to influence technology
adoption as an adopter will have a more positive attitude towards the innovation if
there is a perception it will bring a relative advantage compared to flot adopting it
(Hebert & Benbasat, 1994). When considering an information technology system,
the perception an adopter has of system characteristics will also favor adoption if
the adopter sees positively the quality the system accuracy (Cork & al., 1998) and
the screen design and layout (Sittig & al., 1999). Perceiving that confidentiality and
privacy are secured also has a positive influence on adoption (Anderson & al.,
1986, Gardner & Lundsgaarde, 1994).
Furthermore, the potential adopter’s perception ofthe clinical impact the innovation
will have has an effect on innovation adoption. Accordingly, there will be a greater
rate of adoption if potential adopters perceive the innovation as improving efficient
clinical workflow (Dansky & al., 1999, Gadd & Penrod, 2001), quality of care
(Gardner & Lundsgaarde, 1994, Gadd & Penrod, 2001), workload (Gardner &
Lundsgaarde, 1994) and patients’ satisfaction with the quality of care (Gadd &
Penrod, 2001).
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Physicians and patients as adopters ofthe electronic medicat record
Health professionals’ attitude towards the utilization of information technology has
been the focus ofvarious studies. An assessment ofphysicians’ attitude conceming
the pilot implementations of an outpatient EMR in six practices of a large academic
health system in Pittsburgh found that they were early adopters of the technology
when it had value added for the effort required to use it. The ability of an EMR to
facilitate efficient clinical workflows without negative effects on the valued
relationship they had with their patients was crucial to the acceptance of the
technology (Gadd & Penrod, 2001).
When studying the effects of an EMR on patient care and correspondent clinician
attitudes in a large Health Maintenance Organization (HMO), researchers of the
Kaiser Permanente Center for Health Research in Portland, Oregon, found that most
clinicians felt that an outpatient EMR had improved the quality of patient care,
including the quality of the patient-clinician interaction, the ability to coordinate the
care of patients with other departments, the ability to detect errors, the timeliness of
referrals, and the ability to act on test results in timely fashion (Marshall & Chin,
1998).
A cross-sectional mail survey of active members in the Jndiana Academy of Family
Physicians indicated that EMR users were more likely to practice in urban areas and
that they were more incline to believe that the use of EMRs was beneficial to their
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profession, improved the quality of medical records and reduced enors. The largest
number of wriften comments regarded security and confidentiality issues and non
EMR users believed that there were more security problems involved with EMRs
than with paper-based medical records (Murray & al., 2003). Another study, a
survey of members of the American College of Physicians-American Society of
Internai Medicine revealed that physicians younger than 50 years old who had full
or part-time academic affiliation reported using computers more ftequently for
medical applications. Physicians expressed concems about Internet security,
confidentiality and accuracy. Computer use was not generalized and, while most
respondent used computers and were connected to the Internet, few used them for
clinical management. Respondents nevertheless said that they wanted to increase
their knowledge of computer-based information-source for patient care, EMR
systems and telemedicine (Lacher & al., 2000).
Reasons why physicians may resist the computerization of their practice include
perceived low personal benefits, fear of loss of status, fear of revealing ignorance,
fear of an imposed discipline, fear of wasted time, fear of unwanted accountability
and fear of new demands (Lorenzi & al., 2001). A study about barriers regarding
the use of EMRs at the Beth Israel Hospital, a Harvard teaching hospital, has
concluded that clinician reluctance to type or perform data entry did flot constitute a
significant banier, but concems about privacy and security did (Rind & Safran,
1993).
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A study done to evaluate 75 physicians’ satisfaction regarding the use of an EMR,
the Brigham and Woman’s Integrated Computing system (BICS), showed that
overail satisfaction was correlated with screen design and layout, and flot with
system response time (Sittig & al., 1999).
Fewer studies have looked at patients’ attitude towards the use of EMRs (Bomba &
de Silva, 2001). A 1985 study surveyed patients who had just consulted a doctor
who was using the computer and others who had seen a doctor using more
conventional procedures. No overail negative effects were recorded for patient
reactions, and there was no difference between the control group and the study
group with respect to patients’ perception of the doctor’s attentiveness and rapport,
patients’ satisfaction with the information received, their confidence in the
treatment received and their expected compliance. There was, however, a relation
with post-consultation stress and doctor computer use for patients unfavourable to
the idea of doctors using computers (Brownbridge & al., 1985). A survey done in
Australia of patients over a 13 day period of practice operation revealed that a large
majority ofrespondents stated that the computer based patient record is an essential
technology for health care in the future and that computers have the potential to
improve the information management and efficiency at a medical practice, as well
as the quality of care received. At the same time, patients feit that privacy and
confidentiality issues were dominant concems, as much with an EMR as with a
conventional paper-based record (Bomba & de Silva, 2001).
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A study assessing patients’ satisfaction with their outpatient encounters in a clinic
where and EMR system had been implemented found that patients did flot indicate a
sense of loss of rapport with their physician. They did, as did the physicians, have
concerns about the privacy of the medical information contained in the EMR (Gadd
& Penrod, 2000).
Patient and Physician Attitudes towards Consent
Consent in the health care sector is needed for different types of processes,
including consent to communicate personal health information, consent to
participate in research and consent to treatment. An understanding of patient and
physician characteristics related to consent will help health professionals have a
better understanding of decision-making processes and identify possible physician
bias, with the goal of getting better patient participation in medical treatment and
research. With this goal in mmd, here is a literature review which unearths the
variables related to patients, physicians and consent.
Relevant literature reveals that various patients and physicians characteristics
related to consent requirements has been identified. For the purpose of this study,
we will discuss characteristics specific to consent to share personal health
information and consent to participate in research. We exciude consent for
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treatment as it differs fundamentally from informed consent for research
(Appelbaum & al., 1987; Taub & al., 1926).
Characteristics related to consent have been studied through both quantitative data,
such as patients’ socio economic status, and qualitative data, such as how the
consent procedures are understood.
Quantitative data found in the literature concems predominantly patients’
characteristics in relation to consent, and few research exist regarding physician’s
or other health care professional’s characteristics. k is the patients’ social economic
status that seems to be the most often studied characteristic in order to try to explain
pattems of consent, with mix resuits depending on the research and the study
subjects. Most studies found in the literature study only one aspect of patient’s
socio economic status, such as gender, age or education, but seldom take into
account multiple characteristics.
Patient’s sex and education are not definitive predictors of consent, and study
resuits are not clear about their relationship to consent rate. For example, in the case
of parents giving consent so that their children would participate in a randomized,
double blind, placebo controlled trial of ibuprofen syrup to prevent recurrent febrile
seizure, the sociodemographic status of the parents, mainly sex and education, did
not influence consent rate (van Stuijvenberg & al., 1998). The study ainied at
assessing the quality of the inforrned consent process in a pediatric setting.
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Education will, however, directly influence consent rate in cardiovascular clinical
trials in a study aimed at determining variables contributing to patient participation
in randomized clinical trials while assessing the potential relationship of these
variables to a valid consent process (DeLuca & aÏ., 1995).
Studies taking into account qualitative data related to consent are more abundant
and concem both patient and the physician characteristics. Amongst the research
findings regarding patient characteristics, it has been shown that the perception the
patients have of the usefulness of the procedure or diagnostic to which they are
giving consent positively influences consent rate. Patients who perceive a benefit
from the procedure or diagnostic they are to be undergoing are more likely to give a
positive consent. It has been shown that elderly people who gave their consent to
participate in clinical research had significantly positive feelings about being used
as research subjects and were motivated, amongst other things, by the benefits
others would gain by their participation in the research (Kaye & al., 1990). In the
randomized controlled trial referred to earlier conceming children participating in a
randomized, double blind, placebo controlled trial of ibuprofen syrup to prevent
recurrent febrile seizure, contribution to clinical science and benefit to the child
were the two main factors for parents granting approval (van Stuijvenberg & al.,
1998).
Moreover, patients’ perception of what constitutes informed consent itself and its
usefulness also influences consent rate. Patients’ trust in medical experiments and
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in the integrity of physicians has an impact of their perception of information
disclosure, which in tum has an impact on their willingness to give consent, as
shown in an analysis of patient perceptions on inforrned consent based on 26
clinicai trials (Verheggen & al., 1998). Perception and understanding of what
constitutes consent may iack altogether as patients may flot remember having
signed a consent form, as shown in a study where a telephone survey was conducted
among 314 former surgery patients to ascertain their opinion about informed
consent (Guix Oliver & ai, 1999) and another study asking patients having DNA
stored their perception of consent (Moutel & al., 2001). Also, the elderly show
significantly poorer comprehension of consent information than younger patients
when asked to participate in research (Stanley & al., 1984).
Qualitative data relating to physicians and health professionals define how they can
or may influence a patient’s decision process and medical treatment. Studies show
that physicians have an important role in influencing patients when cornes time to
decide for them whether to undergo a treatment or not. Physicians may also change
to adapt their practice to consent requirements. As an example, when studying
predictors of compliance in taking antidepressant medication, it has been shown
that the amount of time a physician takes to explain the expected duration of
treatment and possible side-effects to a patient is a key factor to compliance, and the
physician’s attitude towards the medication is also important (Demyttenaere, 2003).
Another study shows that physicians may be unwilling to offer patients the
opportunity to participate if they feel that the patient will be resistant to treatment
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change or if the physician does flot see themselves as the “responsible” physician
for the dnig management (Kroenke & Pinhoit, 1990).
More specifically, some data has to do with physicians’ approach towards the
patient and their appreciation of the usefulness of asking for consent before
undertaking a procedure or diagnostic. It has been studied that the interviewer’s
personality in a clinical trial is seen by participants to influence their consent
dispositions in a clinical research setting (Kaye & al., 1990).
Moreover, the physician may see consent as an intrusion into the doctor-patient
relationship (Taylor & Kelner, 1987). Some health researchers argue that the
obligation to ask for patients’ consent to use secondary data limits epidemiological
and public health research (Gostin & Hadley, 1998; Hodge & al., 1999; Lawlor &
Stone, 2001; Buckovich & al., 1999). It is believed that asking for obligatory
consent can compromise many surveillance activities essential for individual and
public health (Verity & Nicoll, 2002), institutionalize health inequalities and reduce
access to services for vulnerable groups (Cassel & Young, 2002) and jeopardise the
methodological integrity ofresearch and audit (Al-Shahi & Warlow, 2000).
It can be resumed that people willing to participate in a new mean of healthcare
deliverance are in fact adopting a new innovation. Early innovation adopters are
shown to be more educated than the average, to have a higher living status, to
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accept change and science and be able to deal with abstraction and to belong to
interconnected social networks.
When a patient’s consent to the transfer of personal health information is required
in the course of the use of the innovation, it has been shown that the patient’s
gender is not related to consent rate while greater age is related poor comprehension
of consent requirements and education may or may not constitute a defining factor
depending ofthe study.
Also, consent rate is positively influenced when a patient perceives a benefit from
granting consent. Furthermore, consent rate will be higher when a physician takes
time to explain the necessity of the requirement and, on the other hand, a physician
may be unwilling to spend time to have a patient participate in a study if he feels
that the patient is reluctant to do so.
The field lias flot been much studied, maybe because studies regarding consent tend
to focus on consent to undergo treatment and not consent to share personal health
information. It would be quite valuable to have additional information regarding
elements that influence consent to share personal health information, such as extra
quantitative (i.e. income) and qualitative (i.e. motives) data on patients, as well and
quantitative and qualitative data on physicians, which is strongly lacking. Studies
and information regarding the context within which consent to share personal health
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information are also scarce, so studies describing particular innovation
characteristics in relation to consent issues.
It is in with the goal of improving consent understanding and bridging the exposed
knowledge gaps that this study defines, using available variables, which physician
characteristics, in combination with patient characteristics, serve as predictors for
consent rates.
Elaboration of the Conceptual Framework
It was necessary to establish how physicians and patients reacted to the introduction
of a new tecbnology to understand technology adoption and to analyze patients’
consent to share personal health information in the context of a structured research.
The link between innovation adoption and consent to particiate in research
The first concept that has to be taken into account relates to the adoption of a new
innovation. More precisely, in the present context, this concept concems the
adoption of a new mean of intervention in health care. Physicians’ and patients’
attitude towards adopting this new mode of intervention has to be explored.
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Characteristics associated to new adopters of an innovation are grouped into three
subclasses. The first of these classes, the socio-economic status, informs us that
early adopters are neither younger nor older that other adopters. They tend to,
however, have more years of formai education, be more literate, have a higher
social status (income, level of living, possession of wealth and occupational
prestige), have a greater degree ofupward mobility, and belonging to a larger social
unit. The second class refers to the “personality variables”, and correspondent
characteristics of early adopters identifies them as having greater empathy than later
adopters, a greater ability to deal with abstraction, a greater rationality, a greater
intelligence, a more favorable attitude toward change, are better able to cope with
uncertainty and risk, a more favorable attitude toward science, being less fatalistic
and having higher aspirations. The third class refers to the “communication
behavior”, and eariy adopters are viewed as having more social participation than
later adopters, being more cosmopolite, having a greater exposure to information
and knowiedge ofiimovations, and having a greater degree of opinion leadership.
Other studies have shown eariy adopters of innovations in the medical field see an
incentive to adopt if there was value added for the effort required to use the
innovation. Physicians that were initial EMR users were more likely to practice in
urban areas and were more inciined to believe that EMRs were beneficial to their
profession, that it improved the quality of medical records and reduced errors than
non-EMR users. Also, physicians younger than 50 years of age who had a full or
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part-time academic affiliation were more likely to use computers for medical
applications.
The second concept that has to be taken into account in the present study relates to
patients’ willingness to give consent to communicate their personal health
information in the context of a health research.
Physicians and other health professionals often view the mandatory procedure as
being an intrusion in the patient-physician relationship and fear that it is detrimental
to individual and public health research and surveillance and that it may reduce
access to services for vuinerable groups.
Patients, however, tend to be inclined to give consent if they perceive that a benefit
will resuit and if they have a trust in the medical experiment and the integrity in the
physicians involved. What is consent and why it is asked, however, is not aiways
clear to patients. Furthermore, research does show that socioeconomic
characteristics of patients did not have a clear effect on consent rate, with the
exception that a higher education seems to correlate with a higher consent rate.
Both concepts have to be taken into account together. It would be possible to study
the effects of adopting a new innovation without having to consider the consent
factor, and it would be possible to study consent rates to communicate personal
health information without the context of a new mean of intervention, but in the
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scenario where both innovation adoption and consent play crucial roles, variables
linked to both concepts have to be studied.
Hypothesis
Literature can be summarized into two main themes that concem both innovation
adoption and consent to communicate personal health information. The first of
these themes relates to the sociodemographic factors that are related to consent rates
and the second theme relates to the attitudinal factors that are related to consent
rates. However, variables obtained in the course of this study are best aimed at
exploring the prior theme. In accordance with literature, the following hypothesis is
suggested:
Sociodemographic variables do not play a definite role when patients are asked
for consent to communicate personal health information in the context of a health
research, with the exception of education which is found to be directly correlated
with a higher consent rate.
This hypothesis will be tested in real life with the data gathered through this study.
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ClAPIER 3- METHODOLOGY
A synthetic study model will 5e used for the study, consisting in investigating
relationships between dependent and independent variables in a system of
interdependency (Contandriopoulos & al., 1990). The study takes the form of a
secondary analysis of existing data, which limits the study parameters to pre
existing variables. Available data will help us understand how consent rate is
influenced in the context of giving consent to communicate personal information
when adopting a new mode of health intervention. A regression statistical analysis
will 5e used to validate the two working hypotheses.
The MOXXI-II Electronic Prescription System
The data used to establish what variables influence patient consent rates when asked
to participate in an electronic medical record study was gathered while undergoing
the MOXXI-II research project.
The goal ofthe MOXXI-II project was, as said before, to test the potential benefits
of implementing an electronic prescription management system for general
practitioners and their respective patients.
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The rationale of this project was to enhance the quality of clinical care that could be
delivered by primary care physicians by improving access to clinical data (dmgs
prescribed by ail physicians, electronic lab result reporting), the uptake of new
knowledge into practice by utilization of computer-generated patient level alerts
and reminders for preventive care, optimal diabetes management and potential
prescribing problems and, finally, to provide a mechanism to monitor the health of
the general population for the public health unit by pilot testing a prototype for
information collection through networked electronic medical records from primary
care physicians.
Study Design
Within the context of the project, a dynamic electronic consent process was
developed and implemented. This prototype was piloted in this project for potential
application in the other parts of the health care system. The physician’s practice
population was defined using medical services daims and thus potentially eligible
patients who could grant access were identified and verified. Physician
authentication was verified through the professional personalized access key and
PIN number. Legally, the RAMQ is flot required to obtain patient consent prior to
the release of prescription daims data, which means that the process was pre-tested
in an environment that was not bound by the legal requirements for written consent
(such as in hospitals). The process for eliciting prescription drug information
through electronic consent worked in the following way. First, the practice
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population was assembled by retrieving ail patients who were seen by the physician
in the past year, and ail subsequent patients who were seen by the physician during
the course ofthe study (dynamic update ofpotentially eligible patients). Second, ail
fihled prescriptions for these patients were pushed to the MOXXI-ll computer server
located at the RAMQ. The electronic consent that interfaced with the RAMQ was
developed by software consultants, and the law and ethics working group defined
guidelines for electronic consent. To access prescription information, the physician
needed to have his or her personalized access key inserted into his or her computer
USB port and enter his or her PIN number. The patient signed the consent for
access dispiayed on the screen while selecting one of several release periods (that
visit only; 6 months; 12 months; or when the patient specified otherwise), which
authorized the physician to obtain information for the specified time period. The
“send” button initiated a FTP transmission of the consent signal to the RÀMQ
MOXXI server, authorizing release of prescription and hospitalization information
for the specified time period. For patients within a physician’s practice that did flot
provide electronic consent, prescription and medical services information from
administrative databases were available in a de-identified format. For the patients
who had not provided consent, it is flot known whether the patient was approached
by the physician to obtain consent and declined or whether the patient was neyer
approached.
In total, 50,657 patients were seen in the enroliment period. Among this pool of
potentially admissible patients identified by the RÀMQ, 1,846 were excluded
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because they were seen only between June 1999 and November 1999, which was
not part ofthe eligibility period, and another 83 patients were removed because they
received only procedure services from the study physician. This lefi a pool of
48,728 patients of whom 181 had a temporary Medicare number or an invalid
Medicare number, and a further 10,293 did flot visit the study physician during the
intervention period. As a resuit, 38,254 were considered eligible, and as of
November 2000, 6,509 had consented. The analysis was based on the initial
consenting 6,509 patients. Ultimately, 9,180 patients consented to participate of the
3 8,254, a participation rate of 24.0%.
Information retrieved from the patient demographic database inciuded age (by 5
year group) and sex. The medical services database provided data on the medical
visits including the type, location (e.g. inpatient, emergency department, private),
diagnosis, treating and referring physician, and date of ail services provided on a
fee-for-service basis (95% of ail services provided in Quebec). The hospitalization
database provided records of ail hospital discharges in Quebec including discharge
diagnoses, type (i.e. emergency room), admission and discharge dates. The generai
practitioner demographics were provided by RAIvIQ and included sex, location of
graduating medical school, year of graduation, and speciaity.
List ofvariables
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The dependent variable, Patient consent indicator, indicates if a patient seen during
the study had provided consent.
Independent variables for patients are in the form of categorized variables.
Table I — Patients’ variables description and source.
Variable Description Categories Source
Sex Patient Sex ofthe patient Female; Male RAMQ
Income Revenu ofthe patient <30000; 30000-37000; RÀMQ (via
37001-48000; >48000 Census
data)
Age Age ofthe patient <30; 31-47; 48-65; >65 RAMQ
Graduation Population without a Graduation; no graduation RAMQ (via
highschool diploma Census
data)
Visits Med. Number ofmedical visits 1-4; 5-10; 1 1-20; >20 RAMQ
Visits Hosp. Number of hospital visits >=1 RAMQ
Visits Emerg. Number of emergency visits >=1 RAMQ
Visits Int. Care Number of intensive care visits >1 RAMQ
Visits GPS Number ofvisits to general 1; 2-3; 4-7; >7 RAMQ
practitioners
Visits Specialists Number ofvisits to specialists >=1 RAMQ
Consultation GPS Number of consultation visits >=1 RAMQ
to general practitioners
Consultation Specialists Number of consultation visits >=1 RAMQ
to specialists
Rx Number of prescriptions by >=1; 1-5; 6-17; 18-43; >43 RAMQ
patient
Pharmacies Number of pharmacies by >1; 1; 2; 3; >3 RAMQ
patient
Unique Prescribing Number ofumque dmg >=1; 1; 2; 3; >3 RAMQ
prescribing physician by
patient
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Independent variables for physicians are in the form ofcategorized variables.
Table II — Physicians’ variables description and source.
Statistical Analyses
Frequency distributions of general practitioner and patient characteristics were
determined and the means, standard deviations (sd) and ranges were reported for
continuous variables. The bivariate statistical analyses have been done using the
chi-square test in accordance with the categorized nature of the data.
Stages of the analyses included an analysis of the distribution of the individual
variables, an analysis of correlation between independent variables and the
dependant variable, and between independent variables within themselves, and an
analysis through multiple regression through multivariate logistic generalized
Variable Description Categories Source
Sex Physician Sex ofthe physician female; Male RAMQ
Grad Year Year of graduation 1970-1979; 1980-1988; RAMQ
>=1989
Grad University Umversity of graduation Université de Montréal; RAMQ
McGill; Sherbrooke;
Other umversity in
CCanada foreign medical
graduate
Patients byMD Total number of patients by 65-1214; 1215-1962; RAMQ
doctor 1963-2840; >2840
Drugs prescribed Number of different drugs 100-454; 455-542; 543- RAMQ
prescribed 626; >626
Rx by MD Number of total prescriptions 926-5477; 5478-8484; RAMQ
written by the smdy doctor 8485-12786; >12787
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estimating equations (GEE), which were used to investigate whether patient or
general practitioner characteristics increased the probability of consenting to
participate. Patients were clustered within general practitioners with an
exchangeable correlation structure. The unit of analysis was the patient with
consent status (yes versus no) as the outcome of interest. Statistical analyses were
conducted using SAS 8.02.
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CHAPTER 4- RESULTS
Patients and Consent Rates
Table III presents characteristics of consenting and non-consenting patients in the
fom of categorized descriptive statistics for the dependent variable. Correlation
was analyzed with the chi-square test. More precisely, it shows the overali
characteristics of the patients considered to be eligible for inclusion in the study,
along with differences that existed between consenting and non-consenting patients.
Overali, male patients were less likely to participate with 14.9% of male patients
giving consent compared to 18.6% of female patients giving consent. The average
income of people consenting to participate was close to $3,000 higher than those
choosing not to participate. The average age of consenting patients was
substantially older that non-consenting patients, with the age of consenting patients
being 57.9 years and non-consenting patients being 45.16 years.
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Table III - Patients’ Demographic Characteristics
Patients Total Consenting Non-consenting lest
N(%) N=3$245 6509 (17.02%) 31736 (82.98%)
Sex N (%) N (%) N (%)
. female 21718 (56.8) 4049 (18.6) 17669 (81.4)
. Male 16527 (43.2) 2460 (14.9) 14067 (85.1)
Income Means ± s.d. Means ± s.d. Means ± s.d.
41193.2±21921.4 43165.7±25569.9 40788.7±21.072.9
N (%) N (%) N (%) <
. <530000 9877 25.8 1633 25.1 8244 26.0 0.0001
. 530000-37000 9692 25.3 1595 24.5 8097 25.5
. 537001-48000 8816 23.1 1475 22.7 7341 23.1
. >548000 9363 24.5 1717 26.4 7646 24.1
. Missing 497 1.3 89 1.4 408 1.3
Age Means ± s.d. Means ± s.d. Means ± s.d.
47.3± 22.2 57.92 ± 17.29 45.16 ± 22.47
N (%) N (%) N (%) <
. 0-30 9379 24.5 467 7.2 8912 28.1 0.0001
• 31-47 9731 25.4 1294 19.9 8437 26.6
. 48-65 9841 25.7 2234 34.3 7607 24.0
. >65 9294 24.3 2514 38.6 6780 21.4
Population without Means ± s.d. Means ± s.d. Means ± s.d.High School diploma 34.89% ± 14.63 33.07 % 14.66 35.26 ± 14.59
Note: The bivariate statisticai analyses have been donc using the chi-square test in accordance with the categorizcd nawre of
the data.
In Table W, showing categorized descriptive statistics for the dependent variable, it
can be observed that, in average, consenting patients made 12 medical visits in the
year prior to the start ofthe study, about one less that those made by non-consenting
patients. Correlation was analyzed with the chi-square test. Overali, 9.0% of
consenting patients were hospitalized in the baseline year in contrast to 9.5% of
non-consenting. Also, non-consenting patients were also more likely to use the
emergency room (29.1% made at least 1 visit in the baseline year in comparison to
23.0% of consenting patients). A disproportionately greater number of consenting
patients made at least one visit to a specialist in the baseline year (75.2%) relative to
57
non-consenting patients (67.0%). In keeping with this observation, fewer patients
were referred to specialists in the non-consenting pool of patients (15.9%) relative
to consenting patients (17.7%).
Table W - Patients’ Medical Services Characteristics
Patients Total Consenting Non-consenting Test
N(%) N=3$245 6509 (17.02%) 31736 (82.98%)
Number ofmedical Means ± s.d Means + s.d Means + s.d
Visits 13.04+21.60 12.34+14.99 13.19+22.72
(%) N (%) N (¾) N (%) N <
1-4 31.1% 11891 24.7 1609 32.4 10282 0.0001
5-10 33.7% 12887 37.0 2406 33.0 10481
11-20 20.3% 7760 23.4 1523 19.7 6237
>20 14.9% 5707 14.9 971 14.9 4736
Number of Hospital visits
% 1 visit(N) 9.4% (3598) 9.0%(584) 9.5%(3014)
Means + s.d. 22.37 + 34.66 14.87 + 22.06 23.82 + 36.43
Number ofEmergency visits
% 1 visit (N) 28.1% (10735) 23.0%(1498) 29.1%(9237) f 0.0001
Means ± s.d 5.51 + 12.24 4.68 + 5.35 5.65 ± 13.00
Number of intensive care visits
% 1 visit (N) J 0.6%(227) 0.5% (32) 0.6% (195) <
Means + s.d L 5.80 + 8.16 3.06 ± 2.23 6.25 + 8.67 0.000 1
58
Table W - Patients’ Medical Services Characteristics (cont’d)
Number ofvisits to GPS Means * s.d Means ± s.d Means ± s.d
8.06± 12.79 7.46±7.90 8.18± 13.57
<
(%) N (%) N (%) N 0.000
1 11.6% 4446 7.5% 490 12.5% 3956
2-3 25.5% 9754 23.7% 1541 25.9% 8213
4-7 31.6% 12071 36.01% 2344 30.7% 9729
morethan7 31.3% 11974 32.8% 2134 31.0% 9840
Visits to Specialist
% 1 visit (N) 68.4% (26158) 75.2% (4895) 67.0% (21263)
.oooi
Means±s.d. 7.62± 15.68 6.70± 10.74 7.83 ± 16.61
Consultation visits to GP’s
% 1 visit (N) 38.6% (14754) 43.8% (2850) 37.5% (11904)
o.ooi
Means*s.d 1.93± 1.83 1.74± 1.24 1.98± 1.94
Consultation visits to Specialïsts
% 1 visit(N) 16.2% (6198) 17.7% (1 152) 15.9% (5046)
Means±s.d 2.00± 2.11 1.72± 1.39 2.06±2.23
Note: The bivanate statistical analyses have been done using the chi-square test in accordance with the categorized nature of
the data.
A higher proportion of consenting patients (57.0%) fihled at least one prescription in
comparison to 46.4% of non-consenting patients, reveals Table V that shows
categorized descriptive statistics for the dependent variable. Correlation was
analyzed with the chi-square test. Among those who fihled a prescription, the
average number of prescriptions fihled by consenting patients was 39.06
prescriptions in the baseline year in comparison to 30.65 prescriptions by non
consenting patients. The average number of pharmacies attended was lower in the
consenting group, an average of 1.62 pharmacies in the baseline in comparison to
1.83 pharmacies by the non-consenting patients. The number of unique drugs
59
prescribed for study patients by the enrolled physicians was 3.05 different drugs for
consenting patients in comparison to 3.21 different drugs for non- consenting
patients.
Table V - Patients’ Pharmaceutical Services Characteristics
Patients Total Consenting Non-consenting Test
N(%) N=3$245 6509 (1 7.02%) 31736 (22.98%)
No.ofRx per patient
< 0.0001
%(N) %(N) %(N)
%Pt 1 i 48.2% (18434) 57.0% (371 1) 46.4% (14723)
.
26.3% (4845) 12.8% (474) 29.7% (4371)
. 6-17 24.6% (4531) 20.4% (758) 25.6% (3773)
.
j$43 24.6% (4543) 32.6%(1208) 22.7% (3335)
. 43 24.5% (4515) 34.2% (1271) 22.0% (3244)
Mean ± s.d. 32.34 ± 49.36 39.06 ± 41.09 30.65 ± 5 1.10
No. of pharmacy by patient
% (N) % (N) % (N) < 0.0001
% 1 pharmacy 48.2% (18434) 57.0% (3711) 46.4% (14723)
. I pharmacy 54.2% (9998) 60.2% (2235) 52.7% (7763)
. 2 27.5% (5070) 26.3% (976) 27.8% (4094)
• 3 10.8% (1985) 8.3% (307) 11.4% (1678)
• >3 7.5%U381) 5.2%(193) 8.1%(1188)
Mean±s.d. 1.79± 1.22 1.62± 1.00 1.83± 1.26
Number of unique dmgs prescribmg physicians by patient
%(N) %(N) %(N) <0.0001
% 1 unique drug 48.2% (18434) 57.0% (3711) 46.4% (14723)
dispen sers by pt
e 1 24.8% (4577) 25.6% (949) 24.6% (3628)
. 2 23.5% (4338) 23.7% (878) 23.5% (3460)
e 3 18.4%(3394) 19.1%(707) 18.3%(2687)
. >3 33.2%(6125) 31.7%U177) 33.6%(4948)
Mean±s.d. 3.18±2.39 3.05±2.17 3.21 ±2.44
Note: The bivariate statistical analyses have been done using the chi-square test in accordance with the categorized nature of
the data.
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Physician Characteristics
Table VI outiines the characteristics of the participating physicians as descriptive
statistics of independent variables. Overail, 15% of participating physicians were
female, all graduated afler 1970 from medical school, and 45% of the physicians
graduated from the University of Montreal. There was an imbalance in the
distribution between the experimental and control groups, in part explained by the
problem of having group practices of different sizes that had to be randomized as a
unit to the experimental or control groups to avoid contamination.
Overail, in the year prior to the start of the intervention, the average number of
patients seen in the prior year by study physicians was 2041, the average practice
size being slightly lower for physicians randomized to the control group relative to
the experimental group.
The average number of different drugs prescribed, as represented by different drug
identification numbers, included in prescriptions written by the study physicians,
was 552.5, and the average number of total prescriptions written by study
physicians in the baseline year for their practice population was 992$.
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Table VI
- Study Physicians’ Characteristics
Study physicians’ Total Participating Control Group Experimental
characteristics N=20 N=9 Group
N=1 1
Sex N (%) N (%) N (%)
• Female 3 (15.0) 2 (22.2) 1 (9.1)
• Male 17 (85.0) 7 (77.8) 10 (90.9)
Year of Graduation N (%) N (%) N (%)
. 1970-1979 13 (65.0) 7 (77.8) 6 (54.6)
. 1980-1988 6 (30.0) 1 (11.1) 5 (45.5)
• Smce 1989 1 (5.0) 1 (11.1) 0 (0)
University of N (%) N (%) N (%)graduation
• Montreal
• McGill 9 (45.0) 2 (22.2) 7 (63.6)
• Sherbrooke 2 (10.0) 0 (0) 2 (18.2)
• Other 1 (5.0) 1 (11.1) 0 (0)
university in
Canada 2 (10.0) 2 (22.2) 0 (0)
• Foreign
Medical 6 (30.0) 4 (44.4) 2 (18.2)
Graduates
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Table VI
- Study Physicians Characteristics (cont’d)
Practice Total Control Group Experimental T-test
characterïstics Participating N=9 Group
N=20 N=11
Total patients by MD Means ± s.d. Means ± s.d. Means ± s.d.
2041.55 ± 997.50 1769.56 ± 2264.09 ± 1251.35 0.0167
504.45
N (%) N (%) N (%)
. 65-1214 5 (25.0) 1 (11.1) 4 (36.4)
• 1215-1962 5 (25.0) 5 (55.6) 0 (0)
. 1963-2840 5 (25.0) 3 (33.3) 2 (18.2)
. >2840 5 (25.0) 0 (0) 5 (45.5)
No. of different drugs Means ± s.d. Means ± s.d. Means ± s.d.
prescribed 552.5 ± 194.03 540.11 ± 179.23 562.64 ± 213.51 0.6328
N (%) N (%) N (%)
. 100-454 5 (25.0) 2 (22.2) 3 (27.3)
. 455-542 5 (25.0) 3 (33.3) 2 (18.2)
. 543-626 5 (25.0) 3 (33.3) 2 (18.2)
. >626 5 (25.0) 1 (11.1) 4 (36.4)
No. of total Rx written Means ± s.d. Means ± s.d. Means ± s.d.
by the study MD 9928.25 ± 6723.39 8788.56 ± 10860.73 ± 0.7811
6417.62 7128.35
N (%) N (%) N (%)
. 926-5477 5 (25.0) 2 (22.2) 3 (27.3)
. 5478-$484 5 (25.0) 4 (44.4) 1 (9.1)
. $485-12786 5 (25.0) 2 (22.2) 3 (27.3)
. > 12787 5 (25.0) 1 (11.1) 4 (36.4)
Note: The bivariate statistical analyses have been done using the T-test in accordance with the quantitative nature of
the data.
Multivariate Analysis
Patient variables integrated into the GEE regression included sex, age, income, the
number of visits to consuit the general practitioner participating in the study, the
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number of emergency room visits and the number of different pharmacies that were
visited. General practitioner variables included sex and the year of graduation,
which was used as an indicator of years of experience in lieu of physician’s age,
since this variable was flot available. Table VI presents the resuits for significant
predictors from the GEE analyses.
Table VII — Multivariate GEE ofpredictors of consent adjusted for physician level
clustering.
Predictors of Consent GEE Odds 95% CI
Estimate Ratio
Patient-level characteristics
Female 0.15 1.17 1.10-1.24
Age:
<30 years Reference
31-47 1.06 2.90 2.60-3.24
48-65 1.76 5.79 5.21-6.43
>65 years 2.07 7.89 7.09-8.78
Income
< $30,000 -0.04 0.96 0.88-1.04
$30,001-37,000 -0.09 0.91 0.84-0.99
$37,001-48,000 -0.07 0.93 0.86-1.01
$4$,000 Reference
Visits to study GP:
< 3 Reference
3-4 0.38 1.46 1.34-1.59
5 040 1.50 1.38-1.62
ER visits 1 -0.46 0.63 0.59-0.68
Pharmacies visited: I Reference
2-3
-0.14 0.87 0.81-0.94
> 3 -0.30 0.74 0.63-0.88
Physician-level characteristics
female 1.38 3.96 3.63-4.32
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Most variables affected significantly the probability that a patient would consent to
participate in the research, with the exception of the general practitioners’ year of
graduation. To be a female general practitioner increased, on the physicians’ side,
the probability that a patient wouÏd offer consent.
Otherwise, patients more likely to give consent to participate in the research project
tended to be older and were more likely to be female patients.
Patients who visited more oflen thefr study general practitioner also were more
likely to give their consent to participate in the research.
However, a higher number of visits to emergency rooms was directly correlated
with a lower consent rate, as was an increased number a visited pharmacies.
The strongest predictor of consent was, when looking at patient-level
characteristics, related to older age, while the stronger predictor for a lower level of
consent was related to a higher number ofvisits do different pharmacies.
It must be noted that it unsure why non-consenting patients refused to participate in
the study, or even if they were asked to do so by the participating general
practitioner. It would be valuable to study if non-consenting patients have been
approached by the physician. However, if these patients have in effect refused to
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give consent to participate in the research, it is to fear that they could also refuse to
participate in this extra study.
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CHAPIER 5- DISCUSSION
Both physician and patient characteristics play a role in influencing consent rate.
Many of these characteristics influence at different levels. Older female patients
with higher income levels, for example, were more likely to consent. As for general
practitioners, female physicians were more likely to enroli patients in the study,
thus getting their consent to participate in the research proj ect.
Discussing the Resuits
$ome resuits ofthe analyses appear to be in une with observations seen in literature.
Hence, when general practitioners tent to enroil more older patients than younger
ones, this would support the hypothesis that that general practitioners enroll patients
when there are value-added benefits (Gadd & Penrod, 2001; Marshall & Chin,
1998), which would be here that older patients have more complete prescription
drug information due to continuous provincial public insurance. General
practitioners do effectively seem to influence positively the use of a new medical
technology when they feel it facilitates efficient clinical workflow and improves the
quality of patient care. This emphasizes the role of opportunity for obtaining
consent as well as the physicians’ feeling that they are the primary physicians
responsible for the care ofthe patient.
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To consuit a female general practitioner increased the probability that a patient
would offer consent. More research would be needed to understand if for example,
this is due to the specific female physicians’ personalities, or to patidnt’s attitudes
towards male and female health professionals.
In the study, patient income is related to a higher consent rate. This would concur
with the theory saying that early adopters of an innovation tend to have a higher
social status that late adopters (Rogers, 1995, pp. 269-272), where the social status
depends on variables such as income, level of living, possession of wealth and
occupational prestige. However, considering that income is but one of those
variables, and that the concept of “social status” may differ from study to study, it is
necessary to be careful when comparing such concepts.
More patient visits to the study general practitioner is directly related to higher
consent rates. This would be interpreted by the fact that a greater number of
appointments increases the confidence level that exists between the health
professional and the patient, making hum more likely to trust the physician and give
consent to the research. It may also be explained by the fact that the physician fias
more time, over more patients visits, to explain the intricacies of the research and
the implications related to granting consent, making the patient more
knowledgeable ofthe benefits ofthe research.
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The results show that more visits to different pharmacies are related to patients less
likely to grant consent. It is uneasy to explain this phenomenon without extra data
but possible explanations could be that the patient does not have a usual pharmacy
to attend, nor a usual physician to see, and is therefore flot interested in participating
in a research where he would not foresee personal benefits. Another possible
explanation would be that the patient is drug-shopping.
There are cases where resuits do not agree with literature findings, or for which no
previous research has been done. While it was said that gender does flot affect
innovation adoption rate (van Stuijvenberg & al., 1998), the resuits show a direct
relation between consent rate in the context of a medical administrative innovation
and sex, whereby women were more inclined to give their consent to participate in
the study.
Study Limitations
This study was based on a secondary analysis of existing data and, because of the
intrinsic nature of such a study, it was not possible to expand the case analysis to all
variables that were either found in the literature or was believed pertinent to
observe.
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A significant limitation relates to the impossibility to determine the nature of
patients’ non-consent, which could be a direct refusai to consent to communicate
personal information to participate in the study when toid about said study by the
physician, or could resuit from the physician flot asking a patient to participate in
the study for whatever reason. It wouid be valuable to look into physicians’
participation rates and patterns in further research and to inquire about reasons for
not invoiving patients, if that situation does indeed occur. The high non-consent rate
of aimost 83% (Table III) tends to support the hypothesis that physicians did flot
ask ail of their patients to participate in the study.
Another important limitation relates to the personaiity factor. In effect, apart from
establishing that patients’ consent rates vary strongiy from one physician to another
and inferring that the physician’s personalities influence resuits, as suggests the
iiterature, there are no availabie personaiity variables. To gather such variables
would strongiy confirm the personaiity-influence inference. In doing this, it wouid
be interesting to also study the general practitioners’ attitudes towards consent in
order to verify if, in effect, their view towards asking for consent influences
patients’ consent rate.
It wouid be vaiuable to have data defining how a physician conveys information
about consent issues. This could validate studies that show that the amount oftime a
general practitioner spends with a patient to expiain the intricacies of a treatment or
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a procedure is directly related to the level of acceptance to undergo the treatment or
procedure.
Many observation related to innovation acceptance cannot be verified with the
studied variables, including the level of living, possession of wealth, occupational
prestige, upward social mobility and belonging to large social units, which are
associated to early adopters.
In the literature, a higher level of education is associated with early adopters of
innovations and higher incidences of consent rates, as well as higher understanding
of the necessity to give consent. Such a variable was flot used in the study.
Understanding the necessity to provide consent is a factor of the patient’s
perception of what constitutes consent, and it’s utility. Information on patients’
perceptions towards the process, particularly regarding their trust in medical
experiments and physicians, and their understanding of consent issues would have
helped compare the study case to literature cases.
These limitations are important to expose and resuits must be construed while
taking them into account. It is by combining and comparing these limitations to the
previous elements of discussion that further subjects ofstudy can be proposed.
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Future Researcli
An overview of results and limitations brings to light that there is a need for more
research involving qualitative data, including through interviews of patients and
physicians. This will help assess their motivation, feeling and understanding of
consent-related issues. More quantitative variables may also be studied, such as the
level of education and occupation.
Other studies performed in other settings but with the same parameters would
likewise be beneficial to the field of study as the present study would be validated.
Finally, it would be important to study how consent rate impacts on the primary
objective of the study, being the introduction of an electronic medical record as a
pharmaceutical tool maximize drug management.
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CHAPTER 6- CONCLUSION
There is an obvious need to maximize drug management through better
administration of drugs and a reduction of adverse drug events and other negative
effects. It is widely believed that information technologies can and will be used to
achieve this goal.
However, the use of information technologies in health care has to follow certain
rules. The crucial nature of personal health data has imposed the necessity to
respect patients’ privacy as they are given care and services. One such
manifestation of the necessary respect of their privacy is the obligation to ask for
their consent to use and communicate personal health data.
The whole process surrounding consent is only starting to be thoroughly
investigated and variables relating to higher and lower consent rates, may they
concem patients, physicians or other elements, have to be more adequately
explored.
This study provides many descriptions of patient and physician characteristics that
influence consent rate, and describes how they interact one with the other, or others.
Hence, it is understood that elements of a patients’ sociodemographic profile will
incite them to give consent, with some elements having more influence than other.
Also, physicians influence patients’ willingness to consent, amongst other ways
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through their seemingly bias consisting in enrolling patients they feel will most
benefit from the research for which they have to give consent. Also, it is evident
that general practitioners influence patients’ motivation towards consent, but fttrther
studies have to be undertaken in this field.
The valuable contribution of the study is that it adds to the base of imowiedge of
factors and causes related to patients giving or flot their consent to participate in
research. It goes further as it investigates consent rates within a scenario of
innovation and personal health information communication. The fact that physician
characteristics were considered in relation with patient characteristics also brought
new elements to understanding of consent issues.
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